Xeno Transplants Corporation
Other OTCTotal Valuation
Xeno Transplants Corporation carries a market capitalization of 4,036.00, placing it among publicly traded companies globally.
| Market Cap | 4,036.00 |
| Enterprise Value | N/A |
Share Statistics
Xeno Transplants Corporation currently has 40.36M shares outstanding.
| Shares Outstanding | 40.36M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -6.73 |
| P/TBV Ratio | -4.70 |
| P/FCF Ratio | 44.55 |
| P/OCF Ratio | -21.37 |
Financial Position
Xeno Transplants Corporation maintains a current ratio of 0.10, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.10 |
| Quick Ratio | 0.10 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -71.09 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Xeno Transplants Corporation's stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -507,197.00, while operating income came in at -507,533.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -507,533.00 |
| Pretax Income | -507,533.00 |
| Net Income | -507,533.00 |
| EBITDA | -507,197.00 |
| EBIT | -507,533.00 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Total book value stands at -659,654.00, with working capital of -945,344.00 providing operational flexibility.
| Cash & Cash Equivalents | 261.00 |
| Total Debt | N/A |
| Net Debt | 480,413.00 |
| Equity (Book Value) | -659,654.00 |
| Book Value Per Share | -0.02 |
| Working Capital | -945,344.00 |
Cash Flow
Xeno Transplants Corporation produced -207,742.00 in operating cash flow over the past twelve months. After subtracting -307,376.00 in capital expenditures, free cash flow totaled -515,118.00 - equivalent to -0.01 per share.
| Operating Cash Flow | -207,742.00 |
| Capital Expenditures | -307,376.00 |
| Free Cash Flow | -515,118.00 |
| FCF Per Share | -0.01 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -9.85 |
| FCF Yield | 2.24 |
Stock Splits
Xeno Transplants Corporation's most recent stock split took place on September 6, 2006 with a 2:5 split ratio.
| Last Split Date | 9/6/2006 |
| Split Ratio | 2:5 |
Scores
Xeno Transplants Corporation posts an Altman Z-Score of -34.73, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -34.73 |